Bio-Works secures two orders from a US customer totaling SEK 1.1 million, reflecting growing North American demand.

Bio-Works expands its WorkBeads product line with the launch of WorkBeads NiMAC and WorkBeads Dsalt chromatography resins.

Bio-Works appoints Jonathan Royce as its new CEO, bringing extensive life sciences expertise to lead the company's next growth phase.

Bio-Works reports strong sales growth in Q1 2020, demonstrating resilient demand for its chromatography products.

Bio-Works confirms uninterrupted operations during the COVID-19 pandemic, assuring customers of continued product supply.

Bio-Works announces a new CEO appointment, marking a new chapter in the company's leadership and strategic direction.

Bio-Works signs a three-year supply agreement, reinforcing customer confidence and providing a stable long-term revenue base.

Bio-Works publishes the report from its Extraordinary General Meeting held on 12 June 2019.

Bio-Works participates in Småbolagsdagen, presenting its business and growth strategy to Swedish investors and analysts.

Bio-Works releases its Q1 2019 quarterly report covering financial performance and key operational developments.